Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amina Zoubeidi

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 18, 2015
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen ReceptorYi Xia, Menghua Wang, Eliana Beraldi, et al.
European Urology|January 14, 2014
Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancerFrançois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
European Urology|June 16, 2016
Corrigendum re: "Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer" [Eur Urol 2014;66:145-55]François Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Plasmid|August 4, 2009
A broad-range of recombination cloning vectors in mycobacteriaJim Sun, Alice Lau, Xuetao Wang, et al.
Oncology Reports|August 12, 2024
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, et al.
Cancer Research|March 4, 2010
Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BADAmina Zoubeidi, Anousheh Zardan, Romina M Wiedmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway InhibitionKirsi Ketola, Ravi S N Munuganti, Alastair Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Molecular Cancer Research : MCR|January 17, 2009
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growthAmina Zoubeidi, Joice Rocha, Fatima Z Zouanat, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Anti-Cancer Agents in Medicinal Chemistry|June 18, 2015
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen ReceptorYi Xia, Menghua Wang, Eliana Beraldi, et al.
European Urology|January 14, 2014
Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancerFrançois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
European Urology|June 16, 2016
Corrigendum re: "Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer" [Eur Urol 2014;66:145-55]François Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Plasmid|August 4, 2009
A broad-range of recombination cloning vectors in mycobacteriaJim Sun, Alice Lau, Xuetao Wang, et al.
Oncology Reports|August 12, 2024
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, et al.
Cancer Research|March 4, 2010
Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BADAmina Zoubeidi, Anousheh Zardan, Romina M Wiedmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway InhibitionKirsi Ketola, Ravi S N Munuganti, Alastair Davies, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Molecular Cancer Research : MCR|January 17, 2009
The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growthAmina Zoubeidi, Joice Rocha, Fatima Z Zouanat, et al.
Cancer Research|November 3, 2007
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activityAmina Zoubeidi, Anousheh Zardan, Eliana Beraldi, et al.
Pageof 14